Lymphocyte Activation Gene-3 Expression Defines a Discrete Subset of HIV-Specific CD8+ T Cells That Is Associated with Lower Viral Load-Reference-Cited by-同舟云学术

Lymphocyte Activation Gene-3 Expression Defines a Discrete Subset of HIV-Specific CD8+ T Cells That Is Associated with Lower Viral Load

Published:2014-06 Issue:6 Volume:30 Page:535-541
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Peña José¹,Jones Norman G.¹,Bousheri Stephanie¹,Bangsberg David R.²,Cao Huyen¹

Affiliation:

1. California Department of Public Health, Richmond, California.

2. Mbarara University of Science and Technology, Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital Center for Global Health, Harvard Medical School, Boston, Massachusetts.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2012.0195

Reference43 articles.

1. LAG-3, a novel lymphocyte activation gene closely related to CD4.

2. Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3)

3. Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-3

4. Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of CD4+ and CD8+ T cells responses in the mixed lymphocyte reaction by flow cytometry and single cell RNA sequencing;Frontiers in Immunology;2024-01-12

2. Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors;Biology;2023-01-30

3. The Role of TIM-3 and LAG-3 in the Microenvironment and Immunotherapy of Ovarian Cancer;Biomedicines;2022-11-05

4. Tumor immunotherapy: Mechanisms and clinical applications;MedComm – Oncology;2022-06

5. Recipient LAG3 deficiency results in antibody-mediated rejection of mouse renal allografts;2022-01-31